| Literature DB >> 16405725 |
Magali Taulan1, Francois Paquet, Angel Argiles, Jacques Demaille, Marie-Catherine Romey.
Abstract
BACKGROUND: Chemical and radiological toxicities related to uranium acute exposure have been widely studied in nuclear fuel workers and military personnel. It is well known that uranyl nitrate induces acute renal failure (ARF). However, the mechanisms of this metal-induced injury are not well defined at the molecular level.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16405725 PMCID: PMC1363347 DOI: 10.1186/1471-2164-7-2
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
List of global analysis studies on the kidney
| Study | Methods | Conditions | Species and tissue |
| Injury or physiologic | |||
| A. Global analysis studies in ARF | |||
| Basile et al. (2005) | microarray | ischemia-reperfusion | Rat kidney |
| Kieran et al. (2003) | microarray | ischemia-reperfusion | Mouse kidney |
| Mishra et al (2003) | microarray | ischemia-reperfusion | Rat kidney |
| microarray | cisplatin | Mouse kidney | |
| Supavekin et al. (2003) | microarray | ischemia-reperfusion | Mouse kidney |
| Yoshida et al. (2002) | microarray | ischemia-reperfusion | Mouse kidney |
| Yoshida et al. (2002) | microarray | ischemia-reperfusion | Rat kidney |
| Huang et al. (2001) | microarray | cisplatin | Rat kidney |
| B. Global analysis providing control positive data to validate our SAGE libraries | |||
| Chabardés-Garonne et al. (2003) | SAGE | normal | Human kidney |
| Cheval et al. (2002) | SADE* | normal | Mouse kidney |
| Elalouf et al (2002) | SADE* | normal | Mouse kidney |
| Schelling et al. (2002) | SAGE | normal | Mouse Kidney |
| Yano et al. (2002) | microarray | normal | Human kidney |
| El-Meanawy et al. (2000) | SAGE | normal/ | Mouse kidney |
| glomerulosclerosis-prone | |||
| Virlon et al. (1999) | SADE* | normal | Mouse kidney |
*SAGE Adaptation for Downsized Extracts
Figure 1Characterization of UN-induced ARF. (A) Influence of UN on renal function. Blood levels of urea and creatinine and urinary levels of glucose and γGT are plotted. The bars represent the mean ± SEM. *p < 0.05 vs control. (B) Light micrographs of renal tissue from UN(-) (left panel) and UN(+) (right panel) group given 5 mg/kg UN intraperitoneally. Proximal tubules (PT), sectioned transversely, are lined by high cuboidal or pyramidal epithelium. A slight loss in the brush border (BB), and large vacuoles (arrow) in proximal tubular cells in comparison with control group are depicted (×40).
Figure 2Summary of the SAGE data. The ratio of the number of occurrences for each given unique tag in both libraries (UN (-) and UN (+)) has been calculated. Tags have been grouped according to their expression ratio (X-Axis). The frequency (Y-Axis) plot of this ratio shows a Gaussian distribution.
List of tags with significant variation in expression level induced by UN injection (p < 0.05). The table includes their frequency and their relevant accession number.
| Tag sequence | Count | Gene name | Accession No. | Regulation (up: +, down: -) | Gene symbol | |
| UN- | UN+ | |||||
| TGACACAGGA | 4 | 0 | cell death-inducing DNA fragmentation factor, alpha subunit-like effector B | - | ||
| TAGGGCAATC | 2 | 12 | SMT3 (supressor of mif two, 3) homolog 2, pseudogene 4 | + | ||
| ATTAACTTGG | 4 | 16 | glutamate dehydrogenase | + | ||
| ATACTAACGT | 53 | 14 | ornithine decarboxylase, structural | - | ||
| TGGATGCCTT | 7 | 1 | alcohol dehydrogenase 1, complex | - | ||
| TGGATCTCTG | 5 | 0 | carbonic anhydrase 4 | - | ||
| CTATAATGCC | 25 | 8 | fructose bisphosphatase 1 | - | ||
| TTGTTCTGAC | 0 | 6 | glucose phosphate isomerase 1 complex | + | ||
| CAGTTTGTAA | 4 | 0 | pyruvate dehydrogenase E1 alpha 1 | - | ||
| ATAAGGGATT | 0 | 6 | UDP-galactose translocator 2 | + | ||
| GAAGAAAGGG | 10 | 1 | platelet/endothelial cell adhesion molecule | - | ||
| GCGAGGGAGC | 4 | 0 | dim1 (S. pombe) | - | Dim-pending | |
| TGCTGCCATT | 0 | 6 | tubulin alpha 6 | + | ||
| CCCTGGGTTC | 32 | 62 | ferritin light chain 1 | + | ||
| TTATGGAAT | 0 | 7 | CD24a antigen | + | ||
| GTTCAAGTGA | 1 | 9 | Ia-associated invariant chain Ag CD74 classe II | + | ||
| TAGGGAATGG | 0 | 5 | interferon-induced protein with tetratricopeptide repeats 3 | + | ||
| CTGAGAGATA | 1 | 13 | lectin, galactose binding, soluble 3 | + | ||
| ATTGGGGGAG | 6 | 18 | osteoclast inhibitory lectin | + | ||
| CAAACACCGT | 7 | 104 | secreted phosphoprotein 1 | + | ||
| TGGGTTGTCT | 149 | 263 | translationally regulated transcript (21 kDa), | + | ||
| TTTTATGTTT | 12 | 21 | tumor necrosis factor, alpha-induced protein 1 (endothelial) | + | ||
| TATACATCCA | 23 | 69 | uromodulin | NM_009470 | + | |
| CTATCCTCTC | 419 | 537 | glutathione peroxidase 3 | + | ||
| ATGTGGTGTG | 29 | 15 | peroxiredoxin 1 | - | ||
| GGTGAGCCTG | 1 | 8 | peroxiredoxin 2 | + | ||
| TATCTGTGCA | 28 | 16 | selenoprotein P, plasma, 1 | - | ||
| AGAAACAAGA | 19 | 6 | superoxide dismutase 1, soluble | - | ||
| TTGCTTCTAT | 12 | 0 | thioether S-methyltransferase | - | ||
| CTACGTTCTC | 2 | 9 | thioredoxin-like 2 | + | ||
| AGCCCTCGGA | 5 | 0 | acetyl-Coenzyme A dehydrogenase, short chain | - | Acads | |
| TTAAGACCTG | 10 | 21 | crystallin, zeta | + | ||
| TAGAATAAAC | 4 | 0 | cytochrome P450, 2d9 | - | ||
| TGTGTGGAAT | 16 | 7 | cytochrome P450, subfamily IV B, polypeptide 1 | - | ||
| TGCCAACGCA | 25 | 10 | hydroxysteroid dehydrogenase-4 | - | ||
| AATTTAATTA | 5 | 0 | phytanoyl-CoA hydroxylase | - | ||
| TGCAGTCATC | 8 | 1 | transgelin | - | ||
| CTCTGGGGCT | 0 | 6 | transgelin 2 | + | ||
| CTAGATTGCG | 4 | 0 | ectonucleoside triphosphate diphosphohydrolase 5 | - | ||
| AAGAAACCAG | 33 | 16 | expressed in non-metastatic cells 2, protein (NM23B) (nucleoside diphosphate kinase) | - | ||
| GTGTAATAAG | 2 | 8 | heterogeneous nuclear ribonucleoprotein A2/B1 | + | ||
| GGGAGCGAAA | 16 | 8 | inhibitor of DNA binding 2 | - | ||
| TACTGTCCTG | 5 | 0 | RNA polymerase 1–3 (16 kDa subunit) | - | ||
| AATGGCTAGC | 13 | 5 | cytochrome c, somatic | - | ||
| GCCAATAGTG | 0 | 5 | endothelial monocyte activating polypeptide 2 | - | ||
| TCACCCAATA | 64 | 44 | eukaryotic translation elongation factor 2 | - | ||
| CTAATAAAGC | 34 | 68 | Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived) | + | ||
| AGATCTATAC | 13 | 4 | ribosomal protein L7 | - | ||
| AACAATTTG | 21 | 52 | ribosomal protein L9 | + | ||
| GGCAAGCCCC | 20 | 42 | ribosomal protein L10A | + | ||
| TGGATCAGTC | 77 | 131 | ribosomal protein L19 | + | ||
| ATTCTCCAGT | 13 | 36 | ribosomal protein L23 | + | ||
| CCCACAAGGT | 16 | 6 | ribosomal protein L27 | - | ||
| GGCTTCGGTC | 55 | 124 | ribosomal protein, large, P1 | + | ||
| TGTAGTGTAA | 26 | 52 | ribosomal protein S8 | + | ||
| TGGCCCAAA | 2 | 12 | ribosomal protein S16 | + | ||
| GCCTTTATGA | 24 | 14 | ribosomal protein S24 | + | ||
| TAAAGAGGCC | 21 | 48 | ribosomal protein S26 | + | ||
| CTAGTCTTTG | 35 | 81 | ribosomal protein S29 | + | ||
| TAACAGTTGT | 5 | 16 | calnexin | + | ||
| GATTGTCAAA | 1 | 11 | FK506 binding protein 3 (25 kD) | + | ||
| AGAGTTCAGA | 13 | 4 | heat shock protein, 60 kDa | - | ||
| GAATAATAAA | 52 | 29 | heat shock 70 kD protein 8 | - | ||
| CCTTGCTCAA | 11 | 27 | cystatin C | + | ||
| GAGAGTGTGA | 13 | 5 | kidney-derived aspartic protease-like protein | - | ||
| ACCATTATAA | 14 | 7 | lysosomal membrane glycoprotein 2 | - | ||
| TAGCTTCCTC | 15 | 37 | sequestosome 1 | + | ||
| TGACCCCGGG | 51 | 88 | ubiquitin A-52 residue ribosomal protein fusion product 1 | + | ||
| CAGATCTTTG | 6 | 19 | ubiquitin C | + | ||
| TGAAATACTT | 31 | 15 | heat-responsive protein 12 | - | ||
| GCACAACTTG | 3 | 15 | calmodulin 2 | + | ||
| GGCTGTTGAA | 0 | 10 | cysteine rich protein | + | ||
| CATACGCATA | 15 | 3 | growth hormone receptor | - | ||
| GCTGCAGTTG | 0 | 5 | guanine nucleotide binding protein, beta 2, related sequence 1 | + | ||
| AGAGACAAGG | 23 | 4 | N-myc downstream regulated 1 | - | ||
| ATCTCCTAGC | 0 | 10 | matrix gamma-carboxyglutamate (gla) protein | + | ||
| AGCACTTTGC | 1 | 10 | Mus musculus, serine threonine kinase pim3, clone MGC:27707 IMAGE:4924687 | + | ||
| GGCAGATGGA | 17 | 8 | parathyroid hormone receptor, PTH R | - | ||
| TGGGGAAGAG | 1 | 8 | phosphatidylethanolamine binding protein | + | ||
| TAACCAATCA | 7 | 19 | RAB5C | + | ||
| AAAATTGCTT | 14 | 0 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | - | ||
| GCTTTGAATG | 40 | 19 | ATPase inhibitor | - | ||
| GAAGGAAACC | 4 | 0 | ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit | - | ||
| GCATACGGC | 5 | 12 | ATP synthase, H+ transporting, mitochondrial F1F0 complex, subunit e | + | ||
| TTATGAAATG | 31 | 58 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1 | + | ||
| CTTGCAAGTG | 40 | 26 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 | - | ||
| ATGGGATTGA | 0 | 21 | glutamate receptor, ionotropic, kainate 1 | + | ||
| AGAGGCTACA | 4 | 0 | solute carrier family 21 (organic anion transporter)mb1 | - | ||
| GACACATACC | 57 | 23 | solute carrier family 22 (organic cation transporter)-like 2 | - | ||
| ACATTTCCAG | 5 | 0 | solute carrier family 27 (fatty acid transporter), mb 2 | - | ||
| TTGTGAGCCA | 23 | 8 | solute carrier family 34 (sodium phosphate), member 1 | - | ||
| GCTCTGATAC | 5 | 0 | sterol carrier protein 2, liver | - | ||
| GAACCTCTCC | 0 | 5 | amyotrophic lateral sclerosis 2 (juvenile) homolog (human) | + | Als2 | |
| GAAGATCTAA | 5 | 0 | DNA segment, Chr 10, Johns Hopkins University 81 expressed | - | ||
| GTCGTGCCAT | 59 | 12 | DNA segment, Chr 7, Roswell Park 2 complex, expressed | - | ||
| TCATTCTCCA | 9 | 0 | erythrocyte protein band 4.1-like 4a | - | ||
| CTCCTGCAGC | 18 | 41 | esterase 10 | + | ||
| CTTCTTTCTG | 0 | 7 | growth arrest specific 6 | + | ||
| TAGCTTTAAA | 45 | 85 | insulin-like growth factor binding protein 7 | + | ||
| GACTTCACGC | 283 | 91 | kidney androgen regulated protein | - | ||
| GCATAGAAAT | 22 | 8 | kidney-specific membrane protein | - | ||
| TAACTGACAA | 4 | 20 | metallothionein 2 | + | ||
| TGACCACGGG | 1 | 9 | myeloid differentiation primary response gene 88 | + | ||
| GCCCCAATAA | 20 | 12 | phosphatidylcholine transfer protein-like | - | ||
| TAATACTCAA | 73 | 49 | upregulated during skeletal muscle growth 5 | - | ||
Figure 3Confirmation of SAGE data. (A). Real-time RT-PCR analysis. The relative fold change of UN(+)/UN(-) is plotted. PCR analyses were performed on cDNA from UN(-) or UN(+) tissues. All values represent the mean ± SEM. *p < 0.05 vs control. (B). Western blot analysis of ODC, TCTP, IGFBP7 and Gal-3 proteins in UN(-) and UN(+) tissues. Fifty micrograms of total cell protein were loaded per lane on a 10% SDS-polyacrylamide gel, and ODC, TCTP, IGFBP7 and Gal-3 were detected by immunoblotting with antibodies against the respective proteins. As a control for proteins loading in SDS-PAGE, an anti-β-actin antibody was used.
Figure 4Putative cellular pathways of UN-mediated nephrotoxicity. The diagram depicts the putative pathways involved in UN-mediated toxicity. This schematic was assembled using the gene expression data from 2 days UN treatment and previous litterature. Up- or down-regulation is denoted by different colors (green and black, respectively). Mechanisms (in purple) such as oxidative stress, apoptosis, inflammation and perturbation of calcium homeostasis might contribute to uranium toxicity. Secondary compensatory mechanisms were evident as increases in tissue regeneration and cellular proliferation.
SYBR Green (a) and Taq Man primers (b) sequences used for RT PCR reactions.
| GeneSymbol | Accession No. | Primer 5' -> 3' sequence | Amplicon size (bp) |
| a. Primers using SYBR Green detection | |||
| Forward 5'-TTGCTGACCTGCTGGATTAC-3' | 112 | ||
| Reverse 5'-CCCGTTGACTGATCATTACA-3' | |||
| Forward 5'-TGGTGGTCCATGAGAAACAA-3' | 75 | ||
| Reverse 5'-TCCCAGCATTTCCAGTCTTT-3' | |||
| Forward 5'-TGTGCAGAAGCCATCTCAAG-3' | 99 | ||
| Reverse 5'-AGATCCAAGAGGGCCTGATT-3' | |||
| Forward 5'-GACCATGAGATTGGCAGTGA-3' | 110 | ||
| Reverse 5'-GGTGCAGGCTGTAAAGCTTC-3' | |||
| Forward 5'-TTGCCACTGATGATTCCAAA-3' | 129 | ||
| Reverse 5'-CATGGAAGCTCACACCAATG-3' | |||
| Forward 5'-CATGGCTGACCAACTGACTG-3' | 103 | ||
| Reverse 5'-CCCCAGCTCCTTTGTTGTTA-3' | |||
| Forward 5'-GCATCCAGCCACCTTATGAT-3' | 105 | ||
| Reverse 5'-ATCCGAAGAGGAGGAAGAGG-3' | |||
| Forward 5'-ACGGTCTGATCCGCAAATAC-3' | 138 | ||
| Reverse 5'-CATGATCGGTTCCACTTGGT-3' | |||
| Forward 5'-CCGGGAGATCGCGGAC-3' | 92 | ||
| Reverse 5'-TTCCACCGATGAGCGAGTC-3' | |||
| b. Primers using Taq Man technology Assay ID (Assay On Demand, Applied Biosystems) | |||
| Mm00446968m1 | |||
| Mm00495104m1 | |||
| Mm00447649m1 | |||
| Mm00441450m1 | |||